Ivacaftor
RxNorm 1243041
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1243041 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: ivacaftor.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
INPrescribable
Ingredient (IN):
Ivacaftor
(Atom ID: 4243197)
PTPrescribable
Designated preferred name (PT):
Ivacaftor
(Atom ID: 6389628)
FNPrescribable
Full form of descriptor (FN):
Ivacaftor (substance)
(Atom ID: 6389631)
PTPrescribable
Designated preferred name (PT):
Ivacaftor-containing product
(Atom ID: 10805571)
FNPrescribable
Full form of descriptor (FN):
Product containing ivacaftor (medicinal product)
(Atom ID: 9258670)
Patient Education
Ivacaftor
Ivacaftor is used to treat certain types of cystic fibrosis (an inborn disease that causes problems with breathing, digestion, and reproduction) in adults and children 4 months of age and older. Ivacaftor should be used only in people with a certain genetic make-up. Your doctor may order a blood test to help decide if this medication is right for you. Ivacaftor is in a class of medications called cystic fibrosis transmembrane conductance regulator (CFTR) potentiators. It works by improving the function of a protein in the body to decrease the build-up of thick mucus in the lungs and improving other symptoms of cystic fibrosis.
[Learn More]
* Please review the disclaimer below.